MarketPulse

CAR-T therapies

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bcc Research

DNA Editing Market to Triple to $67.7B by 2030 on CRISPR Boom

Global DNA read, write, edit market projected to surge from $21.4B in 2024 to $67.7B by 2030, driven by CRISPR advances and genomic diagnostics expansion.
ILMNVRTXTMOBEAMPACBgene therapyCAR-T therapies
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

CRISPR Therapeutics Advances Gene-Editing Platform With First Approved Therapy

CRISPR Therapeutics gains FDA approval for Casgevy, its first gene-editing therapy for rare blood disorders, validating the platform with multiple pipeline candidates in development.
CRSPFDA approvalclinical trials